Allurion Technologies (ALURD) Common Equity (2022 - 2026)

Allurion Technologies (ALURD) Common Equity (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 52.70 Bn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 38.00 Mn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 50.07 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 25.86 Bn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 10.33 Bn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 10.67 Bn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 2.96 Bn
8 Smith & Nephew 28.19 Bn 27.62 Bn - 5.29 Bn
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 12.96 Bn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -77.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -77.91 Mn
Dec 31, 2025 -77.19 Mn
Sep 30, 2025 -82.93 Mn
Jun 30, 2025 -63.98 Mn
Mar 31, 2025 -69.79 Mn
Dec 31, 2024 -77.98 Mn
Sep 30, 2024 -64.79 Mn
Jun 30, 2024 -70.58 Mn
Mar 31, 2024 -66.16 Mn
Dec 31, 2023 -71.30 Mn
Sep 30, 2023 -52.76 Mn
Jun 30, 2023 -71.22 Mn
Mar 31, 2023 -49.66 Mn
Dec 31, 2022 -32.31 Mn
Sep 30, 2022 -20.17 Mn
Jun 30, 2022 -6.71 Mn